Two drug molecules achieve myelin repair in MS disease models
The media in this post is not displayed to visitors. To view it, please go to the original post.
BY THE OPTIMIST DAILY EDITORIAL TEAM Every remyelination drug candidate tested in multiple sclerosis research has failed. A doctoral thesis from the University of Helsinki, defended earlier this month, reports two that didn’t. Tapani Koppinen, working in Associate Professor Merja Voutilainen’s research group, identified two separate drug molecules that successfully triggered myelin regrowth in MS […]
The post Two drug molecules achieve myelin repair in MS disease models first appeared on The Optimist Daily: Making Solutions the News.
Two drug molecules achieve myelin repair in MS disease models | The Optimist Daily
Two drug molecules have triggered myelin regrowth in MS disease models, a result no previous candidate has achieved. Here’s what that means.The Optimist Editorial Team (The Optimist Daily: Making Solutions the News |)
